Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fluid retention, Lymphadenopathy, Myalgia, Pain
Clinical narrative: It hurts.; Injection site has a rash on it.; arm is very red/The injection site is red.; It looks like lot of fluid in there.; tenderness; red rash; Swelling under my ledt armpit; Swelling at injection site; itchy on injection site; had fever; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FLUID RETENTION (It looks like lot of fluid in there.), TENDERNESS (tenderness), RASH ERYTHEMATOUS (red rash), PAIN (It hurts.) and VACCINATION SITE RASH (Injection site has a rash on it.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 012A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gaucher's disease since 1991, Hypertension (High blood pressure) since 2019, Thyroiditis (Thyroid) since 1992 and Triglycerides. Concomitant products included LISINOPRIL and PROPRANOLOL for Blood pressure, VELAGLUCERASE ALFA (VPRIV) for Gaucher's disease, LEVOTHYROXINE for Thyroiditis, FENOFIBRATE for Triglycerides.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, the patient experienced VACCINATION SITE PRURITUS (itchy on injection site), PYREXIA (had fever), CHILLS (chills) and MYALGIA (body aches). On 25-Oct-2021, the patient experienced TENDERNESS (tenderness), RASH ERYTHEMATOUS (red rash), VACCINATION SITE SWELLING (Swelling at injection site) and LYMPHADENOPATHY (Swelling under my ledt armpit). On an unknown date, the patient experienced FLUID RETENTION (It looks like lot of fluid in there.), PAIN (It hurts.), VACCINATION SITE RASH (Injection site has a rash on it.) and VACCINATION SITE ERYTHEMA (arm is very red/The injection site is red.). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency. On 25-Oct-2021, PYREXIA (had fever), CHILLS (chills) and MYALGIA (body aches) had resolved, LYMPHADENOPATHY (Swelling under my ledt armpit) had resolved with sequelae. At the time of the report, FLUID RETENTION (It looks like lot of fluid in there.), PAIN (It hurts.), VACCINATION SITE RASH (Injection site has a rash on it.) and VACCINATION SITE ERYTHEMA (arm is very red/The injection site is red.) outcome was unknown and TENDERNESS (tenderness), RASH ERYTHEMATOUS (red rash), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PRURITUS (itchy on injection site) had not resolved.            Patient had vaccinated first dose on 23-Jan-2021 at 2.30 pm and second dose on 25-Feb-2021 at 10.30 am and experienced events at 03.00 am on 24-Oct-2021.   Most recent FOLLOW-UP information incorporated above includes: On 26-Oct-2021: Follow-up received on 26-OCT-2021. Added patient details, dose 1 and 2 details, concomitant medication information, new events, outcome.